Honda Recalls 41,580 Cars Across Various Models In India
Japanese auto major Honda is recalling 41,580 units of previous generation of Accord, Civic, City and Jazz models in India as part of a global exercise to rectify faulty airbags. The latest exercise takes the overall number of recalled vehicles, equipped with airbags manufactured by Takata, by the company to around 3 lakh in India.
The company, which is present in India through a wholly-owned arm Honda Cars India Ltd (HCIL), announced that the latest recall will impact models which were manufactured in 2012.
"HCIL will voluntarily replace Takata passenger front airbag inflators of 41,580 vehicles of previous generation of Jazz, City, Civic and Accord as part of Honda's precautionary global recall campaign concerning Takata front airbag inflators," HCIL said in a statement.
According to the company, the recall will affect 659 units of the premium sedan Accord, 32,456 units of City, 7,265 units of Jazz and 1,200 units of Civic.
"The replacement will be carried out free of cost at HCIL dealerships across India. The replacement of inflators for the affected models would begin immediately and the company will communicate with customers directly," the company said.
Last year in July, HCIL had recalled 1,90,578 units of the previous generation of Accord, CR-V, Civic, City and Jazz models as part of its global exercise to rectify faulty airbags made by Takata. Millions of vehicles have been recalled across the globe due to defective safety airbag manufactured by Japan's Takata Corp.
It has affected vehicles manufacturers across brands, including BMW, Chrysler, Daimler Trucks, Ford, General Motors, Honda, Mazda, Mitsubishi, Nissan, Subaru and Toyota.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.